Versia Injection

About Versia 500 mcg/ml Injection

Versia Injection is a product of Square Pharmaceuticals PLC. It contains Neostigmine Methyl Sulphate 500 mcg/ml and is given by injection in hospital settings under the supervision of a qualified doctor.

There are 4 brands of Neostigmine Methyl Sulphate listed in Bangladesh. The lowest listed price is Neos-R 500 mcg/ml Injection at ৳ 8.00 per unit.

What is Versia 500 mcg/ml Injection?

Versia Injection, made by Square Pharmaceuticals PLC, contains Neostigmine Methyl Sulphate at a strength of 500 mcg/ml in injection form. It belongs to a group of medicines called anti-cholinesterases. These medicines work by interfering with the breakdown of acetylcholine, a natural chemical messenger in the body, so that its effects last longer. Because of how it acts, Versia Injection is used only in supervised medical settings, such as during surgery or after an operation. It is not a medicine you give yourself at home. A doctor decides whether it is suitable for a particular patient and how it should be given.

Uses of Versia

Versia Injection is used to reverse the effect of certain muscle-relaxing medicines given during surgical anaesthesia. It is also used to prevent and treat abdominal swelling and difficulty passing urine that can occur after an operation, once a mechanical blockage has been ruled out. In some patients it is used for control of myasthenia gravis when oral treatment is not practical. Only a doctor can decide whether this medicine is appropriate.

How to use Versia

Versia Injection is given by a doctor or trained healthcare staff, usually in a hospital. It may be injected slowly into a vein, or given into a muscle or under the skin, depending on the reason it is being used. The doctor decides the dose, the route and how often it is given, and may give another medicine alongside it. Do not attempt to use this injection yourself. Ask the doctor or pharmacist if you have questions about how it is being given.

Side effects of Versia

Common effects include nausea, vomiting, increased salivation, diarrhoea and abdominal cramps, which tend to be more marked at higher doses. Signs of too much medicine include more stomach discomfort, increased bronchial secretions and sweating, involuntary passing of stool or urine, small pupils, involuntary eye movements, slow heart rate, low blood pressure, restlessness, excessive dreaming and weakness. Tell the doctor or nurse promptly if you notice any of these, especially after an injection.

Safety and precautions

Versia Injection must be given only under medical supervision. The doctor should be told about asthma, slow heart rate, a recent heart attack, epilepsy, low blood pressure, parkinsonism, vagotonia or peptic ulcer, and about any allergy to the medicine. It should not be used in peritonitis or in blockage of the intestine or urinary tract. In pregnancy it is category C; there are no adequate studies in pregnant women, and anticholinesterase drugs may cause uterine irritability or premature labour when given into a vein near term. It is not known whether it passes into breast milk. A doctor should be asked before use in pregnancy or breastfeeding.

Frequently asked questions

How should Versia Injection be stored?

Store it in a cool and dry place, protected from light. It is normally kept and handled by hospital or pharmacy staff, so ask them about storage if you are given the injection during a hospital stay.

What is Versia Injection used for and what kind of medicine is it?

It is an anti-cholinesterase medicine containing Neostigmine Methyl Sulphate. It is used to reverse certain muscle-relaxing medicines after surgery, to prevent or treat post-operative abdominal swelling and urinary retention, and sometimes for myasthenia gravis when oral treatment is not practical.

Is Versia Injection safe in pregnancy or breastfeeding?

It is pregnancy category C, and there are no adequate studies in pregnant women; anticholinesterase drugs may cause uterine irritability or premature labour when given into a vein near term. It is not known whether it passes into breast milk. Ask your doctor before use if you are pregnant or breastfeeding.

Who should not receive Versia Injection?

It should not be given to anyone allergic to the medicine, or to patients with peritonitis or a blockage of the intestine or urinary tract. Tell the doctor about asthma, slow heart rate, recent heart attack, epilepsy, low blood pressure, parkinsonism or peptic ulcer before it is given.

Indications

Neostigmine Methyl Sulphate is indicated for-
  • Reversal of nondepolarising neuromuscular blockade for surgical anesthetic procedures
  • The prevention and treatment of post-operative abdominal distention and urinary retention after mechanical obstruction has been excluded.
  • ... Read more
Neostigmine Methyl Sulphate is indicated for-
  • Reversal of nondepolarising neuromuscular blockade for surgical anesthetic procedures
  • The prevention and treatment of post-operative abdominal distention and urinary retention after mechanical obstruction has been excluded.
  • Treatment of the systemic control of Myasthenia Gravis when oral therapy is impractical.

Pharmacology

Neostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. By interfering with the breakdown of acetylcholine, Neostigmine indirectly stimulates both nicotinic and muscarinic receptors. It does cross the blood-brain barrier but only poorly. Neostigmine binds to the anionic site of cholinesterase. The drug blocks the active site of acetylcholinesterase; so the enzyme can no longer break down the acetylcholine molecules before they reach the postsynaptic membrane receptors. This allows for the threshold to be reached so a new impulse can be triggered in the next neuron. In myasthenia gravis there are too few acetylcholine receptors. So with the acetylcholinesterase blocked, acetylcholine can bind to the few receptors and trigger a muscular contraction.

Dosage & Administration

Reversal of the effects of Non-depolarizing Neurormuscular Blocking Agents: The usual dose is 0.5 to 2 mg given by slow intravenous injection over 60 seconds; repeated as required. Total dose should not exceed 5 mg (in exceptional cases). When Neostigmine is administered intravenously, it is recommended that Atropine Sulphate (0.6-1.2 mg) also be given intravenously using separate syringe.

Prevention of post-operative abdominal distention and urinary retention: 0.25 mg intramuscularly or subcutaneously as soon as possible after operation; repeat every 4 6 hours for 2-3 days.

Treatment of post-operative abdominal distention: 0.5 mg intramuscularly or subcutaneously or as required.

Treatment of urinary retention: 0.5 mg intramuscularly or subcutaneously. If urination does not occur within an hour, the patient should be catheterized. After the patient has voided, or the bladder has been emptied, continue the 0.5 mg injection every 3 hours, for at least 5 injections.

Symptomatic control of Myasthenia Gravis: 0.5 mg intramuscularly or subcutaneously. Subsequent dose should be based on the individual patient's response.

Neonates: 50-250 micrograms (0.1 to 0.5 ml) every 4 hours.

Children: 200-500 micrograms (0.4 ml to 1 ml) as recommended.

Interaction

Anti-arrhythmic Procainamide, Quinidine and possibly Propafenone antagonise effect of Neostigmine. Antibacterials, Aminoglycosides, Clindamycin, Lincomycin and Polymyxins antagonise effect of Neostigmine.

Contraindications

Neostigmine is contraindicated in patients with known hypersensitivity to the drug. It is also contraindicated in patients with peritonitis or mechanical obstruction of the intestinal or urinary tract.

Side Effects

Nausea, vomiting, increased salivation, diarrhoea and abdominal cramps (more marked with high doses). Signs of overdose are increased gastrointestinal discomfort, bronchial secretions and sweating, involuntary defecation and micturition, miosis, nystagmus, bradycardia, hypotension, agitation, excessive dreaming and weakness eventually leading to fasciculation and paralysis.

Pregnancy & Lactation

Pregnancy Category C. There are no adequate or well-controlled studies of Neostigmine in either laboratory animals or in pregnantwomen. It is not known whether Neostigmine can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Neostigmine should be given to a pregnant woman only if clearly needed.

Nonteratogenic Effects: Anticholinesterase drugs may cause uterine irritability and induce premature labor when given intravenously to pregnant women near term.

Nursing Mothers: It is not known whether Neostigmine is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions from Neostigmine in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

Asthma, bradycardia, recent myocardial infarction, epilepsy, hypotension, parkinsonism, vagotonia, peptic ulceration. Atropine or other antidote to muscarinic effccts may be necessary (particularly when Neostigmine is given by injection), but it should not be given routinely as it may mask signs of overdose.

Storage Conditions

Store in a cool and dry place, protected from light.

Alternative brands of Neostigmine Methyl Sulphate

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.